Drug research analytics giant Medidata, has selected gyro New York, part of Dentsu Aegis Network as its creative agency after a formal review. The shop has been tasked with developing and launching Medidata’s new brand campaign, “Architecture of Hope.”
The client—which offers cloud-based solutions for analyzing clinical research in the drug development field--is collaborating with gyro:human, the agency’s global healthcare practice.
The firms plan to roll out a series of integrated programs designed to illustrate the important work of the life sciences industry and the pivotal role that Medidata plays in the pursuit of new therapies for patients.
Simon Mouyal, Medidata’s chief marketing officer, stated that “gyro understands the complexity of the healthcare space, and we’re confident that together we will elevate our brand and communicate the value that our unified platform brings to the entire clinical trials ecosystem.”
The Medidata platform has been used by nearly 800 customers around the world—supporting more than 12,000 clinical studies.
The “Architecture of Hope” messaging is designed to highlight the company’s expertise in study planning, conduct and optimization, as well as site support and patient engagement.
“Our healthcare expertise was central to helping us understand not only the solutions themselves, but also the healthcare audiences and the higher purpose that Medidata serves,” added Wendy Lurrie, Managing Director of gyro New York and gyro:human.